Last $0.24 USD
Change Today +0.0118 / 5.17%
Volume 5.0K
PBIO On Other Exchanges
As of 8:10 PM 01/27/15 All times are local (Market data is delayed by at least 15 minutes).

pressure biosciences inc (PBIO) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/19/14 - $0.78
52 Week Low
10/20/14 - $0.13
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

pressure biosciences inc (PBIO) Related Businessweek News

No Related Businessweek News Found

pressure biosciences inc (PBIO) Details

Pressure BioSciences, Inc. develops pressure cycling technology (PCT) in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples and is used in various areas of life sciences, including genomic, proteomic, and small molecule sample preparation, as well as in pathogen inactivation, protein purification, control of chemical reactions, and immunodiagnostics areas of life sciences. The company offers Barocycler instrumentation products, including Barocycler NEP3229, Barocycler NEP2320, Barocycler HUB440, PCT MicroTube Adapter Kit, and The Shredder SG3 laboratory instrumentation that subjects a sample to cycles of pressure from ambient to ultra-high levels and then back to ambient. It also distributes Constant Systems cell disruption equipment, parts, and consumables. In addition, the company offers Baracycler consumable products, such as PULSE Tubes, which transmit the power of PCT from the Barocycler instrument to the sample; Non-Disk PULSE Tubes that offer variable sample volumes; ProteoSolve for Systems Biology, which is a PCT-dependent method for the simultaneous extraction, isolation, and fractionation of nucleic acids, proteins, and lipids from animal and plant samples used in laboratory research. Its Baracycler consumable products also include ProteoSolve for Conventional Extraction that is a PCT-dependent kit for the extraction of proteins from various samples; and mitochondria isolation kits that contain the chemical ingredients required for a scientist to extract mitochondria from skeletal muscle and lung tissue for subsequent analysis. Pressure BioSciences, Inc. serves researchers at academic laboratories; government agencies; and biotechnology, pharmaceutical, and other life science institutions. The company, formerly known as Boston Biomedica, Inc., was founded in 1978 and is based in South Easton, Massachusetts.

9 Employees
Last Reported Date: 03/31/14
Founded in 1978

pressure biosciences inc (PBIO) Top Compensated Officers

Founder, Chief Executive Officer, President, ...
Total Annual Compensation: $294.3K
Senior Vice President of Engineering
Total Annual Compensation: $197.6K
Vice President of Research and Development
Total Annual Compensation: $165.6K
Compensation as of Fiscal Year 2013.

pressure biosciences inc (PBIO) Key Developments

Pressure BioSciences, Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 12:00 PM

Pressure BioSciences, Inc. Presents at 8th Annual OneMedForum 2015, Jan-12-2015 12:00 PM. Venue: San Francisco Marriott Marquis, Parc 55 Wyndham, Union Square, San Francisco, California, United States. Speakers: Richard T. Schumacher, Founder, Chief Executive Officer, President, Secretary, Treasurer, Clerk and Director.

Pressure BioSciences Proposes Amendment to Articles of Organization

Pressure BioSciences, Inc. announced that at the company's special meeting of shareholders held on December 19, 2014, the company approved an amendment to the Company's articles of organization to increase the authorized number of shares of Common Stock by up to 50,000,000 shares, such increase to be effected through one or more amendments to articles of organization to be filed with the Secretary of the Commonwealth of Massachusetts at the discretion of the Board of Directors at any time during the twelve months following the date of the Meeting.

Pressure BioSciences, Inc., Annual General Meeting, Dec 19, 2014

Pressure BioSciences, Inc., Annual General Meeting, Dec 19, 2014., at 16:00 US Eastern Standard Time. Location: 14 Norfolk Avenue. Agenda: To elect one Class III Director to hold office until the 2017 Annual Meeting of Stockholders and until his successor is duly elected and qualified; to ratify the appointment of Marcum LLP as independent registered public accounting firm for 2014; to approve an amendment to its articles of organization to increase the authorized number of shares of Common Stock ; to approve an amendment to its articles of organization to increase the authorized number of shares of Preferred Stock; to approve an amendment to its articles of organization ; to consider and vote on a proposal to approve the adjournment of the Meeting, if necessary or appropriate, to solicit additional proxies, in the event that there are not sufficient votes at the time of such adjournment to approve any of proposals; and to consider and vote upon any matters incidental to the foregoing purposes and any other matters which may properly come before the Meeting or any adjourned session thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PBIO:US $0.24 USD +0.0118

PBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PBIO.
View Industry Companies

Industry Analysis


Industry Average

Valuation PBIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PRESSURE BIOSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at